04:42 PM EDT, 04/09/2024 (MT Newswires) -- Fady Ibraham Malik, Executive Vice President, Research & Development, on April 09, 2024, sold 32,605 shares in Cytokinetics ( CYTK ) for $2,422,918. Following the Form 4 filing with the SEC, Malik has control over a total of 138,567 shares of the company, with 138,567 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1061983/000112760224012715/xslF345X03/form4.xml

Price: 75, Change: -0.05, Percent Change: -0.07